Here are 10 highlights.
1. The company saw record first quarter revenue of $15.5 million, compared to $11.7 million in the same time period in 2017. This boost was due to growth in recurring revenue from kit sales, services and other.
2. U.S. revenue jumped 27 percent to $14.2 million, up from $11.2 million in the first quarter of 2017.
3. Mazor reported international revenue of $1.3 million, reflecting a 160 percent boost from the first quarter of 2017.
4. Gross margin was 58.3 percent for the first quarter of 2018.
5. Total operating expenses were $10.5 million, down from $13.3 million in the first quarter of 2017. This is because of lower selling and marketing expenses under the Medtronic partnership.
6. Mazor’s operating loss was $1.4 million in the first quarter of 2018, compared to $5.7 million in the same period the year prior.
7. The company’s first quarter net loss was $1.3 million, down from $5.2 million for the first quarter of 2017.
8. The company’s cash provided by operating activities was $2.7 million in the first quarter of 2018. The cash, cash equivalents and investments totaled $114.5 million.
9. Mazor reported 33,000-plus performed cases in the first quarter of 2018.
10. Mazor CEO Ori Hadomi said, “We are also advancing and expanding our technology development efforts with Medtronic, and I am pleased to share that commercialization of the Mazor X platform, which integrates Medtronic’s Stealth navigation and offers a unique robot-guided implant solution that eliminates the need for guidewires, is expected at the end of 2018.”
More articles on devices:
36 orthopedic, spine devices receive FDA 510(k) clearance in April
3 things to know about Xenco Medical’s SETx Technology
Globus Medical partners with the Society of Lateral Access Surgery: 3 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
